Home LiteratureArticle Details
PMID: 11847100 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis.

The EMBO journal ·Vol. 21 ·No. 4 ·2002-02-15 ·Pages 514-24

Furstoss O, Dorey K, Simon V, Barilà D, Superti-Furga G, Roche S

Abstract

The mechanism by which the ubiquitously expressed Src family kinases regulate mitogenesis is not well understood. Here we report that cytoplasmic tyrosine kinase c-Abl is an important effector of c-Src for PDGF- and serum-induced DNA synthesis. Inactivation of cytoplasmic c-Abl by the kinase-inactive Abl-PP-K(-) (AblP242E/P249E/K290M) or by microinjection of Abl neutralizing antibodies inhibited mitogenesis. The kinase-inactive SrcK295M induced a G(1) block that was overcome by the constitutively active Abl-PP (AblP242E/P249E). Conversely, the inhibitory effect of Abl-PP-K(-) was not compensated by Src. c-Src-induced c-Abl activation involves phosphorylation of Y245 and Y412, two residues required for c-Abl mitogenic function. Finally, we found that p53 inactivation and c-myc expression, two cell cycle events regulated by Src during mitogenesis, also implied c-Abl: c-Abl function was dispensable in cells deficient in active p53 and inhibition of c-Abl reduced mitogen-induced c-myc expression. These data identify a novel function of cytoplasmic c-Abl in the signalling pathways regulating growth factor-induced c-myc expression and we propose the existence of a tyrosine kinase signalling cascade (PDGFR/c-Src/c-Abl) important for mitogenesis.

MeSH Terms
Amino Acid Sequence Animals Cells, Cultured Cytoplasm/metabolism DNA Replication/physiology Genes, myc Mice Mitosis Molecular Sequence Data Phosphorylation Platelet-Derived Growth Factor/physiology Proto-Oncogene Proteins c-abl/physiology Proto-Oncogene Proteins pp60(c-src)/physiology Signal Transduction
Chemicals
Platelet-Derived Growth Factor Proto-Oncogene Proteins c-abl Proto-Oncogene Proteins pp60(c-src)
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Furstoss Olivia
CNRS UPR-1086 CRBM, 1919 route de Mende, F-34293 Montpellier, France.
Dorey Karel
Simon Valérie
Barilà Daniela
Superti-Furga Giulio
Roche Serge
References (43)
43 references, click to expand
  1. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells.
    Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7696-700 PMID: 8356071
  2. STAM2, a new member of the STAM family, binding to the Janus kinases.
    FEBS Lett. 2000 Jul 14;477(1-2):55-61 PMID: 10899310
  3. The nuclear tyrosine kinase c-Abl negatively regulates cell growth.
    Cell. 1994 Apr 8;77(1):121-31 PMID: 7512450
  4. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.
    Cell. 1994 Apr 8;77(1):53-62 PMID: 8156598
  5. Ternary complex factors: growth factor regulated transcriptional activators.
    Curr Opin Genet Dev. 1994 Feb;4(1):96-101 PMID: 8193547
  6. DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases.
    Mol Cell Biol. 1995 Feb;15(2):1102-9 PMID: 7823926
  7. Receptor protein-tyrosine kinases and their signal transduction pathways.
    Annu Rev Cell Biol. 1994;10:251-337 PMID: 7888178
  8. v-Abl activates c-myc transcription through the E2F site.
    Mol Cell Biol. 1995 Dec;15(12):6535-44 PMID: 8524218
  9. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src.
    Nature. 1995 Nov 30;378(6556):509-12 PMID: 7477410
  10. The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products.
    EMBO J. 1996 Apr 1;15(7):1583-95 PMID: 8612582
  11. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.
    Nat Med. 1996 May;2(5):561-6 PMID: 8616716
  12. Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling.
    J Biol Chem. 1996 Jul 12;271(28):16798-806 PMID: 8663329
  13. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.
    Nature. 1996 Jul 18;382(6588):272-4 PMID: 8717045
  14. Requirement of phospholipase C gamma, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways.
    EMBO J. 1996 Sep 16;15(18):4940-8 PMID: 8890167
  15. Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport.
    Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15174-9 PMID: 8986783
  16. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation.
    Mol Cell Biol. 1997 Apr;17(4):1824-31 PMID: 9121430
  17. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction.
    Immunity. 1997 Apr;6(4):449-57 PMID: 9133424
  18. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
    Oncogene. 1997 Jul 10;15(2):203-11 PMID: 9244355
  19. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Nat Genet. 1998 Mar;18(3):280-2 PMID: 9500553
  20. Essential roles for the Abl and Arg tyrosine kinases in neurulation.
    Neuron. 1998 Dec;21(6):1259-72 PMID: 9883720
  21. Ras enhances Myc protein stability.
    Mol Cell. 1999 Feb;3(2):169-79 PMID: 10078200
  22. Chronic myeloid leukemia.
    N Engl J Med. 1999 Apr 29;340(17):1330-40 PMID: 10219069
  23. Cycling, stressed-out and nervous: cellular functions of c-Abl.
    Trends Cell Biol. 1999 May;9(5):179-86 PMID: 10322452
  24. Anti-apoptotic activity of p53 maps to the COOH-terminal domain and is retained in a highly oncogenic natural mutant.
    Oncogene. 1999 Aug 19;18(33):4699-709 PMID: 10467417
  25. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF.
    Genes Dev. 1999 Sep 15;13(18):2400-11 PMID: 10500097
  26. Src family tyrosine kinases and growth factor signaling.
    Exp Cell Res. 2000 Jan 10;254(1):1-13 PMID: 10623460
  27. A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK.
    EMBO J. 2000 Jan 17;19(2):273-81 PMID: 10637231
  28. Slap negatively regulates Src mitogenic function but does not revert Src-induced cell morphology changes.
    Mol Cell Biol. 2000 May;20(10):3396-406 PMID: 10779329
  29. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.
    J Pharmacol Exp Ther. 2000 Oct;295(1):139-45 PMID: 10991971
  30. c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines.
    J Biol Chem. 2000 Nov 10;275(45):35631-7 PMID: 10964922
  31. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling.
    Mol Cell Biol. 2000 Dec;20(23):9018-27 PMID: 11074000
  32. Identification of a novel immunoreceptor tyrosine-based activation motif-containing molecule, STAM2, by mass spectrometry and its involvement in growth factor and cytokine receptor signaling pathways.
    J Biol Chem. 2000 Dec 8;275(49):38633-9 PMID: 10993906
  33. Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase.
    Nat Med. 2001 Feb;7(2):228-34 PMID: 11175855
  34. Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation.
    Mol Cell. 2000 Dec;6(6):1413-23 PMID: 11163214
  35. Regulation of c-myc expression by PDGF through Rho GTPases.
    Nat Cell Biol. 2001 Jun;3(6):580-6 PMID: 11389443
  36. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis.
    Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7319-24 PMID: 11404481
  37. Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.
    Oncogene. 2001 Dec 6;20(56):8075-84 PMID: 11781820
  38. Growth regulation of a cellular tumour antigen, p53, in nontransformed cells.
    Nature. 1984 Mar 8-14;308(5955):199-201 PMID: 6366574
  39. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein.
    Nature. 1992 May 7;357(6373):82-5 PMID: 1533443
  40. Dominant negative MYC blocks transformation by ABL oncogenes.
    Cell. 1992 Sep 18;70(6):901-10 PMID: 1525828
  41. S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues.
    Nucleic Acids Res. 1993 Mar 25;21(6):1498 PMID: 8464749
  42. No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen.
    Oncogene. 2000 Jun 1;19(24):2867-9 PMID: 10851090
  43. Differential complementation of Bcr-Abl point mutants with c-Myc.
    Science. 1994 Apr 15;264(5157):424-6 PMID: 8153630
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
2002-02-15
Pages
514-24
Language
English
Region
England
NLM ID
8208664
PMCID
PMC125864
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]